Samuel Lagercrantz: “Companies that do this successfully will take the lead”

The development of new medicines and medical technologies should not focus too narrowly on prolonging life. It is equally important to develop treatments that r...

Merck KGaA acquires American company in €3.0 billion deal

Germany’s Merck is completing the acquisition of Springwork Therapeutics for 3 billion euros.

The Swedish National Board of Health and Welfare rejects prioritising andrology as a speciality

Male infertility can be linked to a shorter lifespan and several severe diseases, but when couples who want children are examined, the focus is on the woman. Ex...

Forskare utvecklar kontaktlinser för att bota grön starr

Kinesiska forskare har utvecklat kontaktlinser som ska känna av om trycket i ögat stiger och därefter frigöra läkemedel för att sänka trycket vid behov. Förhopp...

Orbán's extended arm becomes health commissioner in the EU

Hungarian Olivér Várhelyi may soon become the most influential official for the healthcare and pharmaceutical industry in the EU. Várhelyi, who is close to Hung...

New cell therapy raises hope for curing type 1 diabetes – "Never succeeded before"

For the first time, a patient with type 1 diabetes has undergone an islet transplantation using genetically modified insulin-producing cells that do not require...

Nivågivare med Bluetooth för smidig och enkel kommunikation

Nivågivare FLR från Kuebler erbjuder kontinuerlig nivåmätning som bygger på flottörprincipen. Med Bluetooth slipper du kabeldragning och får en smidig och enkel...

Novo Nordisk establishes new factory in Denmark

Novo Nordisk establishes a new production facility in Odense, Denmark, an investment of 8.5 billion Danish kroner.

A new scientific event in Gothenburg

Life Science Sweden is holding an event in Gothenburg for the first time.

The new Swedish life science strategy – “It will consolidate Sweden as a leader”

Clinical trials and precision health are emphasised as key areas in the new national life science strategy.

ZEISS introduces the new Smartzoom 100

The future of digital microscopy for efficient optical inspections.

Drug development booms in Medicon Valley

When it comes to developing new medicines, the Öresund region is one of the top performers in the EU. Companies working on commission for pharmaceutical compani...

Mikael Kubista lämnar Tataa: "Världen förändras"

Tataa Biocenter byter ut delar av ledningen, inklusive vd:n och medgrundaren Mikael Kubista. Förändringen sker, enligt ett pressmeddelande, för att ”stödja före...

Pharma Outsourcing igång på Stockholm Waterfront

Christina Östberg Lloyd satsar på eget – ”Jag är full av energi”

Efter över tjugo år på olika tjänster inom life science-företag satsar Christina Östberg Lloyd på eget som konsult. ”Detta öppnar upp helt nya perspektiv och mö...

ZEISS Quality Innovations at CONTROL

May 6-9, 2025 in Stuttgart.

Her company is developing a new tablet form obesity drug

Obesity and diabetes are the primary targets of a new tablet treatment under development by Malmö-based Pila Pharma. The company’s ambition is to take on the bi...

Quretech granted a European patent for a new type of antibiotic

The European patent provides protection until 2041. Previously, the patent was granted in China, and the application is currently under review in the USA, India, and Japan.

Nocebo – the evil twin that makes you feel worse

The placebo effect is well known in healthcare, but not so its opposite: nocebo. “The effect is small, but it can have major repercussions,” says Uppsala resear...

Large study: The benefits and risks of obesity medications

Medications such as Ozempic can reduce the risk of a range of different diseases and health conditions but also increase the risk of others. This is according t...

600 million SEK for life science - "Should not be the country of moderation"

Sweden will prioritize excellence over breadth in research. This was made clear when the government presented the research proposition for the next four years.

Life Science Sweden´s international issue is on its way

A new issue of Life Science Sweden is on its way to print, packed with news, interviews and reports.

Affibody AB

Lonza